Burzynski Research Institute, Inc. Share Price Other OTC
Equities
BZYR
US1231591058
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 4.83M 403M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | - |
Net cash position 2022 | 3.38K 282K | Net cash position 2023 | 934 77.89K | EV / Sales 2023 | - |
P/E ratio 2022 |
-3
x | P/E ratio 2023 |
-3.68
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 18.99% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 81 | 01/84/01 | |
Director of Finance/CFO | 46 | 01/12/01 | |
Tomasz Janicki
PRN | Corporate Officer/Principal | 58 | 01/12/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 81 | 01/84/01 | |
Director/Board Member | 44 | 08/11/08 | |
Director/Board Member | 60 | 06/21/06 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |